<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Vliet, E.A. van</title>
    <link>http://repub.eur.nl/res/aut/13509/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries (Article)</title>
      <link>http://repub.eur.nl/res/pub/8355/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To improve the biocompatibility of stents using a
      phosphorylcholine coated stent as a form of biomimicry. INTERVENTIONS:
      Implantation of phosphorylcholine coated (n = 20) and non-coated (n = 21)
      stents was performed in the coronary arteries of 25 pigs. The animals were
      killed after five days (n = 6), four weeks (n = 7), and 12 weeks (n = 8),
      and the vessels harvested for histology, scanning electron microscopy, and
      morphometry. MAIN OUTCOME MEASURES: Stent performance was assessed by
      studying early endothelialization, neointima formation, and vessel wall
      reaction to the synthetic coating. RESULTS: Stent thrombosis did not occur
      in either group. Morphometry showed no significant differences between the
      two study groups at any time point. At five days both the coated and
      non-coated stents were equally well endothelialised (91% v 92%,
      respectively). At four and 12 weeks there was no difference in intimal
      thickness between the coated and non-coated stents. Up to 12 weeks
      postimplant the phosphorylcholine coating was still discernible in the
      stent strut voids, and did not appear to elicit an adverse inflammatory
      response. CONCLUSION: In this animal model the phosphorylcholine coating
      showed excellent blood and tissue compatibility, unlike a number of other
      polymers tested in a similar setting. Given that the coating was present
      up to 12 weeks postimplant with no adverse tissue reaction, it may be a
      potential candidate polymer for local drug delivery.</description>
    </item>
  </channel>
</rss>